Synlogic
Business Services · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
301 Binney St Ste 402, Cambridge, Massac...Phone Number
(617) 401-9975Website
www.synlogictx.comRevenue
<$5 MillionStock Symbol
SYBXIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Synlogic
Synlogic is bringing the transformative potential of synthetic biology to medicine. With a premiere synthetic biology platform that leverages a reproducible, modular approach to microbial engineering, Synlogic designs Synthetic Biotic medicines that target validated underlying biology to treat disease in new ways. Synlogic's proprietary pipeline includes Synthetic Biotics for the treatment of metabolic disorders including phenylketonuria (PKU), enteric hyperoxaluria, and homocystinuria. The company is also building a portfolio of partner-able assets in immunology.Explore more
Synlogic Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Synlogic your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Synlogic has new funding data
Check if Synlogic has recently received funding, and reach out quickly before it becomes old news!
Click to see if Synlogic had a recent Job posting/layoffs
Check out if Synlogic is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Synlogic launches new products
Synlogic, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Synlogic recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Synlogic
Recommended Actions
Find VP level buyers at Synlogic
Find 3 more new buyers
Compare Similar Companies to Synlogic
Compare insights from companies similar to Synlogic, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Synlogic is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Synlogic is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Synlogic.
Synlogic financials insights
Gather financial insights about Synlogic, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Series A
$34.4M
2016
Series B
$40M
2017
Series C
$42M
2018
Stock Offering
$57.5M
Stock Offering
$30M
2019
Corporate Investment
$80M
Synlogic Tech Stack
A closer look at the technologies used by Synlogic
See more technologies
Most Recent Scoops
Event
reported a quorum for its stockholders' meeting with 9,633,925 shares, representing approximately 82.36% of outstanding common stock, present in person or by proxy.
Corporate Strategy, Governance
Event
Synlogic announced an advisory vote on the compensation of named executive officers as disclosed in the company's proxy statement for the stockholders' meeting.
Compensation & Benefits, Corporate Strategy, Finance, Governance, HR Operations, Operations
Project
Synlogic announced the proposed ratification of KPMG, LLP as the company's Independent Auditors for the current fiscal year, as appointed by the Board of Directors.
Audit, Internal Audit & Control, Corporate Strategy, Finance, Governance
Event
Synlogic announced its upcoming stockholders' meeting, scheduled for November 2024, to vote on electing a Class 3 director, advisory vote on executive compensation, and ratifying KPMG LLP as the independent auditor.
Corporate Strategy, Governance
Earnings
Earnings, Finance
Synlogic News & Media
Synlogic Reports Second Quarter 2024 Financial Results
WINCHESTER, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today reported financial results for the second quarter 2024 and provided a corporate update.Synlogic Reports First Quarter 2024 Financial Results
CAMBRIDGE, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today reported financial results for the first quarter 2024 and provided a corporate update.Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results
CAMBRIDGE, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today reported financial results for the fourth quarter and full year ending December 31, 2023.Phenylketonuria Market to Exhibit Significant Growth, Assesses DelveInsight | Key Companies - BioMarin, Synlogic, PTC Therapeutics, Jnana Therapeutics, Homology Medicines
The phenylketonuria market is expected to grow in 7MM in the coming years due to factors like an increase in the patient pool and the expected entry of emerging therapies by leading pharma and biotech companies. The phenylketonuria market is expected to grow in 7MM in the coming years due to factors like an increase in the patient pool and the expected entry of emerging therapies by leading pharma and biotech companies.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Synlogic
Sign Up For FreeTo access detailed company insights
Synlogic is bringing the transformative potential of synthetic biology to medicine. With a premiere synthetic biology platform that leverages a reproducible, modular approach to microbial engineering, Synlogic designs Synthetic Biotic medicines that target validated underlying biology to treat disease in new ways. Synlogic's proprietary pipeline in... Read More
